Related Experiment Video
Updated: Apr 28, 2026

10:02
Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
2.8K
Immunological properties of inulin-type fructans
Leonie Vogt1, Diederick Meyer, Gerdie Pullens
1a Immunoendocrinology, Department of Pathology and Medical Biologyw , University Medical Center Groningen , Hanzeplein 1, 9700 RB Groningen , The Netherlands.
Critical Reviews in Food Science and Nutrition
|June 11, 2014
Summary
Inulin-type fructans modulate the immune system through indirect and direct mechanisms, showing promise for disease prevention. Further research is needed to fully understand their effects and optimize their use.
Area of Science:
- Immunology
- Microbiology
- Nutrition Science
Background:
- Inulin-type fructans (ITFs) are oligosaccharides with potential health benefits.
- Studies have explored ITFs in colon cancer, inflammatory diseases, and infection prevention.
- This paper focuses on the immunomodulating effects of ITFs.
Purpose of the Study:
- To discuss the immunomodulating effects of inulin-type fructans.
- To explore the indirect and direct mechanisms by which ITFs influence the immune system.
- To highlight the potential of ITFs in disease prevention.
Main Methods:
- Review of existing studies on inulin-type fructans and their effects.
- Discussion of indirect mechanisms involving gut microbiota and short-chain fatty acids.
- Exploration of potential direct interactions between ITFs and immune cells (e.g., dendritic cells) and gut epithelium via pattern recognition receptors (PRRs).
Main Results:
- Indirect immunomodulation occurs via stimulation of beneficial bacteria and production of short-chain fatty acids.
- Direct immunomodulation may involve ITFs binding to PRRs on dendritic cells, influencing cytokine production and antigen presentation.
- ITFs may also interact with PRRs on gut epithelial cells, affecting barrier function.
Conclusions:
- Inulin-type fructans are potent immunomodulating food components with significant potential for disease prevention.
- Further research is required to elucidate specific mechanisms, dose-effect relationships, and structure-function aspects of ITFs.
- Understanding these factors will optimize the application of ITFs in health and disease management.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
952
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
952
Renewal of Intestinal Stem Cells
2.7K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.7K

